References
Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage. 2007;15:981–1000.
Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16:137–62.
Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010;18:476–99.
Disclosures
Dr. McAlindon has provided consultative services to Flexion and Allergan, has received lecture fees from IBSA and Novartis, and has research funding from the NIH and Novartis. Dr. McAlindon is an inventor on a patent for performance of web-based clinical trials.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McAlindon, T. Osteoarthritis Research Society International (OARSI) Classification and Guidelines. HSS Jrnl 8, 66–67 (2012). https://doi.org/10.1007/s11420-011-9231-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11420-011-9231-2